Yuejiao Huang

Dr. Yuejiao Huang

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2022 in Molecular Medicine
Verified
Journal Article
Open access
PDF file
YZYu Zhang
Yu Zhang
XGXinliang Gu
Xinliang Gu
XQXinyue Qin
Xinyue Qin
YHYuejiao Huang
Yuejiao Huang
SJShaoqing Ju
Shaoqing Ju
Background: Gastric cancer (GC) is one of the diseases that endanger human health with high morbidity and mortality. The positive rates of traditional biomarkers in the diagnosis of GC are low, so it is necessary to find biomarkers with high sensitivity to increase the detection rate. tRNA-derived small RNAs (tsRNAs) are novel small non-coding RNAs with specific biological functions and aberrant expression in cancer. In this study, we focused on the potential of tRNA-derived small RNAs as GC biomarkers.Methods: The differentially expressed tsRNAs in three pairs of GC tissues were screened with high-throughput sequencing and verified using the TCGA database and Quantitative real-time PCR. The methodological evaluation of tRF-23-Q99P9P9NDD was verified by agarose gel electrophoresis, RIN evaluation, and Sanger sequencing. The Chi-square test was used to evaluate the relationship between the tRF-23-Q99P9P9NDD expression and clinicopathological parameters. Kaplan–Meier survival analysis was used to evaluate the effect of the tRF-23-Q99P9P9NDD expression on survival. Additionally, the receiver operating characteristic curve (ROC) was used to evaluate the diagnostic efficacy of tRF-23-Q99P9P9NDD in GC.Results: Differential expression of serum tRF-23-Q99P9P9NDD could distinguish GC patients from gastritis patients and healthy donors. Chi-square test showed that high expression of tRF-23-Q99P9P9NDD was significantly associated with T stage, lymph node metastasis, TNM stage, and nerve/vascular invasion. Kaplan–Meier curve showed that patients with high expression of tRF-23-Q99P9P9NDD had a lower survival rate than patients with low expression of this biomarker. ROC analysis showed that, compared with conventional biomarkers, the efficacy of tRF-23-Q99P9P9NDD was higher, which was improved by the combination of biomarkers, and even in the early stages. Finally, we preliminarily predicted the downstream of tRF-23-Q99P9P9NDD in GC cells.Conclusions: The expression of tRF-23-Q99P9P9NDD in GC serum can identify GC patients, and it has higher efficacy than conventional biomarkers even in the early stages. Furthermore, tRF-23-Q99P9P9NDD can monitor the postoperative conditions of GC patients.

14 July 2022 in Molecular Medicine
Verified
Journal Article
Open access
PDF file
SQShiyi Qin
Shiyi Qin
QZQi Zhang
Qi Zhang
YXYanhua Xu
Yanhua Xu
SMShuo Ma
Shuo Ma
TWTianyi Wang
Tianyi Wang
SJShaoqing Ju
Shaoqing Ju
Circular RNAs (circRNAs) have become a research hotspot in recent years with their universality, diversity, stability, conservativeness, and spatiotemporal specificity. N6-methyladenosine (m6A), the most abundant modification in the eukaryotic cells, is engaged in the pathophysiological processes of various diseases. An increasing amount of evidence has suggested that m6A modification is common in circRNAs and is associated with their biological functions. This review summarizes the effects of m6A modification on circRNAs and their regulation mechanisms in cancers, providing some suggestions of m6A-modified circRNAs in cancer therapy.

17 May 2024 in Journal of Zhejiang University-SCIENCE B
Verified
Journal Article
Closed access
PDF file
YZYu Zhang
Yu Zhang
XGXinliang Gu
Xinliang Gu
YLYang Li
Yang Li
XLXun Li
Xun Li
YHYuejiao Huang
Yuejiao Huang
SJShaoqing Ju
Shaoqing Ju
Gastric cancer (GC) is one of the most common gastrointestinal tumors. As a newly discovered type of non-coding RNAs, transfer RNA (tRNA)-derived small RNA

3 June 2022 in Experimental Hematology & Oncology
Verified
Journal Article
Open access
PDF file
XGXinliang Gu
Xinliang Gu
YZYu Zhang
Yu Zhang
XQXinyue Qin
Xinyue Qin
SMShuo Ma
Shuo Ma
YHYuejiao Huang
Yuejiao Huang
SJShaoqing Ju
Shaoqing Ju
Transfer RNAs (tRNAs) promote protein translation by binding to the corresponding amino acids and transporting them to the ribosome, which is essential in protein translation. tRNA-derived small RNAs (tsRNAs) are derived fragments of tRNAs that are cleaved explicitly under certain conditions. An increasing amount of research has demonstrated that tsRNAs have biological functions rather than just being degradation products. tsRNAs can exert functions such as regulating gene expression to influence cancer progression. Their dysregulation is closely associated with various cancers and can serve as diagnostic and prognostic biomarkers for cancer. This review summarizes the generation, classification, and biological functions of tsRNAs, and highlights the roles of tsRNAs in different cancers and their applications as tumor markers.

1 March 2024 in Genes & Diseases
Verified
Journal Article
Open access
YZYu Zhang
Yu Zhang
XGXinliang Gu
Xinliang Gu
YLYang Li
Yang Li
YHYuejiao Huang
Yuejiao Huang
SJShaoqing Ju
Shaoqing Ju
With the development of sequencing technology, transfer RNA (tRNA)-derived small RNAs (tsRNAs) have received extensive attention as a new type of small noncoding RNAs. Based on the differences in the cleavage sites of nucleases on tRNAs, tsRNAs can be divided into two categories, tRNA halves (tiRNAs) and tRNA-derived fragments (tRFs), each with specific subcellular localizations. Additionally, the biogenesis of tsRNAs is tissue-specific and can be regulated by tRNA modifications. In this review, we first elaborated on the classification and biogenesis of tsRNAs. After summarizing the latest mechanisms of tsRNAs, including transcriptional gene silencing, post-transcriptional gene silencing, nascent RNA silencing, translation regulation, rRNA regulation, and reverse transcription regulation, we explored the representative biological functions of tsRNAs in tumors. Furthermore, this review summarized the clinical value of tsRNAs in cancers, thus providing theoretical support for their potential as novel biomarkers and therapeutic targets.

16 August 2022 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
QZQi Zhang
Qi Zhang
SQShiyi Qin
Shiyi Qin
CPChunlei Peng
Chunlei Peng
YLYupeng Liu
Yupeng Liu
YHYuejiao Huang
Yuejiao Huang
SJShaoqing Ju
Shaoqing Ju